Deoxycytidylate deaminase activity in non-stimulated and phytohemagglutinin-stimulated human lymphocytes, and in leukemic cells.
Deoxycytidylate deaminase isolated from normal human lymphocytes and from mononuclear leucocytes from patients with acute lymphoblastic leukemia, chronic lymphocytic leukemia and acute monocytic leukemia has been characterized in regard to the substrate, dAMP and the allosteric regulators dCTP and dTTP. The enzymes exhibited sigmoidal initial velocity versus dCMP concentration whereas in the presence of the activator, dCTP, Michaelis-Menten kinetics were obtained. At saturating substrate concentrations dTTP acted as an allosteric inhibitor of the enzyme isolated from non-stimulated as well as from stimulated lymphocytes. However, the enzymes isolated from the leukemic cells had lost the allosteric regulation by dTTP. At low substrate concentrations the competitive inhibitor, dAMP, activated all the enzymes. This activation was abolished in the presence of dCTP which indicates that dAMP might be involved in the regulation of dCMP deaminase activity and thus influence the dCTP and dTTP pools under physiological conditions.
D000368:Aged; D003844:DCMP Deaminase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D003854:Deoxyribonucleotides / Q000494:pharmacology; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007938:Leukemia / Q000201:enzymology* / Q000276:immunology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000201:enzymology* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009709:Nucleotide Deaminases / Q000378:metabolism*; D010835:Phytohemagglutinins / Q000494:pharmacology
D003854:Deoxyribonucleotides; D010835:Phytohemagglutinins; D009709:Nucleotide Deaminases; D003844:DCMP Deaminase